(BF-B) Brown-Forman - Ratings and Ratios
Spirits, Wines, Whiskey, Vodkas, Tequilas, Bourbons, Liqueurs
BF-B EPS (Earnings per Share)
BF-B Revenue
Description: BF-B Brown-Forman
Brown-Forman Corporation is a leading manufacturer and distributor of premium spirits and wines, boasting a diverse portfolio of renowned brands such as Jack Daniels, Woodford Reserve, and Herradura. The companys extensive global presence spans across multiple regions, including the United States, Europe, and Latin America, with a strong distribution network that caters to both retail customers and consumers.
The companys brand portfolio is a significant strength, with many of its brands holding a premium position in their respective categories. The Jack Daniels brand, in particular, is a global icon, and its continued growth and expansion into new markets are crucial to the companys success. Other notable brands, such as Woodford Reserve and Old Forester, also contribute to the companys premium spirits offerings.
From a financial perspective, Brown-Forman Corporation has demonstrated a commitment to generating strong returns on equity, with a Return on Equity (ROE) of 23.19%. The companys dividend yield and payout ratio are also worth monitoring, as they indicate the companys ability to return value to shareholders. Additionally, key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin will be essential in evaluating the companys future prospects.
To further analyze the companys prospects, it is essential to examine its operational efficiency, including its ability to manage production costs, optimize its supply chain, and invest in effective marketing strategies. The companys ability to innovate and expand its product portfolio, as well as its capacity to navigate the complex and evolving regulatory landscape of the spirits industry, will also be critical in driving long-term success.
BF-B Stock Overview
Market Cap in USD | 13,128m |
Sub-Industry | Distillers & Vintners |
IPO / Inception | 1984-09-07 |
BF-B Stock Ratings
Growth Rating | -87.4% |
Fundamental | 61.6% |
Dividend Rating | 56.4% |
Return 12m vs S&P 500 | -49.3% |
Analyst Rating | 3.0 of 5 |
BF-B Dividends
Dividend Yield 12m | 2.98% |
Yield on Cost 5y | 1.29% |
Annual Growth 5y | 4.65% |
Payout Consistency | 96.2% |
Payout Ratio | 50.7% |
BF-B Growth Ratios
Growth Correlation 3m | 43% |
Growth Correlation 12m | -85.7% |
Growth Correlation 5y | -90.6% |
CAGR 5y | -26.12% |
CAGR/Max DD 3y | -0.41 |
CAGR/Mean DD 3y | -0.92 |
Sharpe Ratio 12m | -1.42 |
Alpha | -58.88 |
Beta | 0.993 |
Volatility | 38.69% |
Current Volume | 3387.8k |
Average Volume 20d | 3448.7k |
Stop Loss | 26.1 (-4.6%) |
Signal | -1.01 |
Piotroski VR‑10 (Strict, 0-10) 5.0
Net Income (844.0m TTM) > 0 and > 6% of Revenue (6% = 236.9m TTM) |
FCFTA 0.07 (>2.0%) and ΔFCFTA 2.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 67.91% (prev 59.45%; Δ 8.46pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.09 (>3.0%) and CFO 741.0m <= Net Income 844.0m (YES >=105%, WARN >=100%) |
Net Debt (2.23b) to EBITDA (1.25b) ratio: 1.78 <= 3.0 (WARN <= 3.5) |
Current Ratio 2.79 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (473.0m) change vs 12m ago 0.00% (target <= -2.0% for YES) |
Gross Margin 59.02% (prev 59.64%; Δ -0.63pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 48.22% (prev 49.86%; Δ -1.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 10.11 (EBITDA TTM 1.25b / Interest Expense TTM 115.0m) >= 6 (WARN >= 3) |
Altman Z'' 6.11
(A) 0.33 = (Total Current Assets 4.18b - Total Current Liabilities 1.50b) / Total Assets 8.17b |
(B) 0.57 = Retained Earnings (Balance) 4.67b / Total Assets 8.17b |
(C) 0.14 = EBIT TTM 1.16b / Avg Total Assets 8.19b |
(D) 1.09 = Book Value of Equity 4.55b / Total Liabilities 4.18b |
Total Rating: 6.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.64
1. Piotroski 5.0pt = 0.0 |
2. FCF Yield 3.80% = 1.90 |
3. FCF Margin 14.79% = 3.70 |
4. Debt/Equity 0.68 = 2.28 |
5. Debt/Ebitda 2.16 = -0.31 |
6. ROIC - WACC 5.70% = 7.12 |
7. RoE 21.77% = 1.81 |
8. Rev. Trend -67.96% = -5.10 |
9. EPS Trend 4.68% = 0.23 |
What is the price of BF-B shares?
Over the past week, the price has changed by -0.83%, over one month by -9.38%, over three months by +6.38% and over the past year by -39.69%.
Is Brown-Forman a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BF-B is around 20.47 USD . This means that BF-B is currently overvalued and has a potential downside of -25.18%.
Is BF-B a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 10
- Sell: 3
- Strong Sell: 2
What are the forecasts/targets for the BF-B price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 31.7 | 16% |
Analysts Target Price | 31.7 | 16% |
ValueRay Target Price | 22.8 | -16.8% |
Last update: 2025-09-10 02:42
BF-B Fundamental Data Overview
CCE Cash And Equivalents = 471.0m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 15.4134
P/E Forward = 16.835
P/S = 3.3252
P/B = 3.2706
P/EG = 3.9081
Beta = 0.515
Revenue TTM = 3.95b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 1.25b USD
Long Term Debt = 2.08b USD (from longTermDebt, last quarter)
Short Term Debt = 626.0m USD (from shortTermDebt, last quarter)
Debt = 2.70b USD (Calculated: Short Term 626.0m + Long Term 2.08b)
Net Debt = 2.23b USD (from netDebt column, last quarter)
Enterprise Value = 15.36b USD (13.13b + Debt 2.70b - CCE 471.0m)
Interest Coverage Ratio = 10.11 (Ebit TTM 1.16b / Interest Expense TTM 115.0m)
FCF Yield = 3.80% (FCF TTM 584.0m / Enterprise Value 15.36b)
FCF Margin = 14.79% (FCF TTM 584.0m / Revenue TTM 3.95b)
Net Margin = 21.38% (Net Income TTM 844.0m / Revenue TTM 3.95b)
Gross Margin = 59.02% ((Revenue TTM 3.95b - Cost of Revenue TTM 1.62b) / Revenue TTM)
Tobins Q-Ratio = 3.37 (Enterprise Value 15.36b / Book Value Of Equity 4.55b)
Interest Expense / Debt = 0.93% (Interest Expense 25.0m / Debt 2.70b)
Taxrate = 19.61% (212.0m / 1.08b)
NOPAT = 934.9m (EBIT 1.16b * (1 - 19.61%))
Current Ratio = 2.79 (Total Current Assets 4.18b / Total Current Liabilities 1.50b)
Debt / Equity = 0.68 (Debt 2.70b / last Quarter total Stockholder Equity 3.99b)
Debt / EBITDA = 2.16 (Net Debt 2.23b / EBITDA 1.25b)
Debt / FCF = 4.62 (Debt 2.70b / FCF TTM 584.0m)
Total Stockholder Equity = 3.88b (last 4 quarters mean)
RoA = 10.33% (Net Income 844.0m, Total Assets 8.17b )
RoE = 21.77% (Net Income TTM 844.0m / Total Stockholder Equity 3.88b)
RoCE = 19.54% (Ebit 1.16b / (Equity 3.88b + L.T.Debt 2.08b))
RoIC = 13.85% (NOPAT 934.9m / Invested Capital 6.75b)
WACC = 8.15% (E(13.13b)/V(15.83b) * Re(9.67%)) + (D(2.70b)/V(15.83b) * Rd(0.93%) * (1-Tc(0.20)))
Shares Correlation 3-Years: -84.85 | Cagr: -0.14%
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 71.53% ; FCFE base≈512.8m ; Y1≈484.2m ; Y5≈457.8m
Fair Price DCF = 20.52 (DCF Value 6.23b / Shares Outstanding 303.6m; 5y FCF grow -7.22% → 3.0% )
EPS Correlation: 4.68 | EPS CAGR: -9.24% | SUE: -0.14 | # QB: False
Revenue Correlation: -67.96 | Revenue CAGR: -5.96%
Additional Sources for BF-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle